The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q96GI7
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
BC009447 - Homo sapiens family with sequence similarity 89, member A, mRNA (cDNA clone MGC:15887 IMAGE:3530481), complete cds. HZ043350 - JP 2015510401-A/440: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ081976 - JP 2015514392-A/440: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408806 - JP 2015528002-A/1403: CHIRAL CONTROL. LF404447 - JP 2015509366-A/440: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LG052140 - KR 1020150036642-A/1406: CHIRAL CONTROL. MA353978 - JP 2018075017-A/440: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MP045618 - Sequence 440 from Patent EP3401394. MP084288 - Sequence 440 from Patent EP3401393. HI965578 - Sequence 863 from Patent WO2010139812. HI966022 - Sequence 342 from Patent WO2010139811. HI966888 - Sequence 342 from Patent WO2010139810. HV594754 - JP 2010539959-A/135: Micromirs. HW413637 - WO 2014003053-A/86: Method for screening pancreatic cancer and test kit therefor. HW799106 - WO 2014192907-A/212: Method for detecting miRNA used for differentiating disorders causing motor neuropathy. HW824052 - JP 2015502176-A/113: Methods and Kits for Detecting Subjects at Risk of Having Cancer. HZ043316 - JP 2015510401-A/406: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074643 - JP 2013535982-A/734: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081942 - JP 2015514392-A/406: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ157311 - JP 2015130862-A/135: Micromirs. HZ479633 - JP 2015535430-A/139: TERMINALLY MODIFIED RNA. HZ789564 - JP 2016504050-A/1309: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401616 - Sequence 863 from Patent WO2011080318. JA402594 - Sequence 863 from Patent WO2011080315. JA403601 - Sequence 863 from Patent WO2011080316. JA406232 - Sequence 863 from Patent EP2336353. JA427121 - Sequence 454 from Patent WO2011072177. JA429758 - Sequence 863 from Patent WO2011095623. JB620828 - Sequence 808 from Patent WO2013063544. JC512296 - Sequence 2549 from Patent WO2014113089. LF161298 - JP 2016513950-A/1364: Oligomers with improved off-target profile. LF404413 - JP 2015509366-A/406: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LP726648 - Sequence 342 from Patent EP2883966. LP818918 - Sequence 342 from Patent EP3296406. LP938860 - Sequence 342 from Patent EP3184651. LQ069884 - Sequence 208 from Patent EP2964234. LQ970703 - Sequence 113 from Patent EP2800820. LY404819 - KR 1020160117535-A/124: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA260058 - JP 2017505623-A/124: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA353944 - JP 2018075017-A/406: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA405869 - WO 2018155427-A/643: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA643385 - JP 2017113010-A/1309: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731269 - JP 2017140048-A/139: TERMINALLY MODIFIED RNA. MP045584 - Sequence 406 from Patent EP3401394. MP084254 - Sequence 406 from Patent EP3401393. MS834717 - Sequence 863 from Patent EP3112479. MA800438 - JP 2018183181-A/1309: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.